706363

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 17, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
149821 CFR 211.122(b)Labeling and packaging improperly approved/released